BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38515943)

  • 21. Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs".
    Su IH; Lund JL; Gaber CE; Sanoff HK; Strassle PD; Duchesneau ED
    Oncologist; 2023 Jul; 28(7):e588-e589. PubMed ID: 37210593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study.
    Noda T; Takahashi H; Tei M; Nishida N; Hata T; Takeda Y; Ohue M; Wada H; Mizushima T; Asaoka T; Uemura M; Kobayashi S; Murata K; Satoh T; Doki Y; Eguchi H;
    Ann Gastroenterol Surg; 2023 May; 7(3):479-490. PubMed ID: 37152774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent.
    Famularo S; Milana F; Cimino M; Procopio F; Costa G; Galvanin J; Paoluzzi Tomada E; Bunino FM; Palmisano A; Donadon M; Torzilli G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal Cancer.
    Xiao BY; Zhang X; Cao TY; Li DD; Jiang W; Kong LH; Tang JH; Han K; Zhang CZ; Mei WJ; Xiao J; Pan ZZ; Li YF; Zhang XS; Ding PR
    J Natl Compr Canc Netw; 2023 Jan; 21(1):60-66.e5. PubMed ID: 36630898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Cervantes A; Adam R; Roselló S; Arnold D; Normanno N; Taïeb J; Seligmann J; De Baere T; Osterlund P; Yoshino T; Martinelli E;
    Ann Oncol; 2023 Jan; 34(1):10-32. PubMed ID: 36307056
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.
    Hao Z; Parasramka S; Chen Q; Jacob A; Huang B; Mullett T; Benson AB
    Oncologist; 2023 Jan; 28(1):48-58. PubMed ID: 36200844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients.
    Milana F; Famularo S; Luberto A; Rimassa L; Scorsetti M; Comito T; Pressiani T; Franzese C; Poretti D; Di Tommaso L; Personeni N; Rodari M; Pedicini V; Donadon M; Torzilli G
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and feasibility of neoadjuvant chemotherapy as a surgical bridge for acute left-sided malignant colorectal obstruction: a retrospective study.
    Zhang J; Deng J; Hu J; Zhong Q; Li J; Su M; Liu W; Lv M; Xu T; Lin D; Guo X
    BMC Cancer; 2022 Jul; 22(1):806. PubMed ID: 35864459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From "Cure" to "Care": The Role of the MultiDisciplinary Team on Colorectal Cancer Patients' Satisfaction and Oncological Outcomes.
    Lucarini A; Garbarino GM; Orlandi P; Garofalo E; Bragaglia L; Laracca GG; Canali G; Pecoraro A; Mercantini P;
    J Multidiscip Healthc; 2022; 15():1415-1426. PubMed ID: 35785259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.
    Zhou Z; Han X; Sun D; Liang Z; Wu W; Ju H
    Front Oncol; 2022; 12():855915. PubMed ID: 35785215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    Cercek A; Lumish M; Sinopoli J; Weiss J; Shia J; Lamendola-Essel M; El Dika IH; Segal N; Shcherba M; Sugarman R; Stadler Z; Yaeger R; Smith JJ; Rousseau B; Argiles G; Patel M; Desai A; Saltz LB; Widmar M; Iyer K; Zhang J; Gianino N; Crane C; Romesser PB; Pappou EP; Paty P; Garcia-Aguilar J; Gonen M; Gollub M; Weiser MR; Schalper KA; Diaz LA
    N Engl J Med; 2022 Jun; 386(25):2363-2376. PubMed ID: 35660797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy-Induced Liver Injury in Patients with Colorectal Liver Metastases: Findings from MR Imaging.
    Donati F; Cioni D; Guarino S; Mazzeo ML; Neri E; Boraschi P
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.
    Calistri L; Rastrelli V; Nardi C; Maraghelli D; Vidali S; Pietragalla M; Colagrande S
    World J Gastroenterol; 2021 Dec; 27(46):7866-7893. PubMed ID: 35046618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Autologous Breast Reconstruction Complications by Type of Neoadjuvant Chemotherapy Regimen.
    Olawoyin OM; Mehta S; Chouairi F; Gabrick KS; Avraham T; Pusztai L; Alperovich M
    Plast Reconstr Surg; 2021 Dec; 148(6):1186-1196. PubMed ID: 34644277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors.
    Hollebecque A; Chung HC; de Miguel MJ; Italiano A; Machiels JP; Lin CC; Dhani NC; Peeters M; Moreno V; Su WC; Chow KH; Galvao VR; Carlsen M; Yu D; Szpurka AM; Zhao Y; Schmidt SL; Gandhi L; Xu X; Bang YJ
    Clin Cancer Res; 2021 Dec; 27(23):6393-6404. PubMed ID: 34465599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial.
    Hansdotter P; Scherman P; Petersen SH; Mikalonis M; Holmberg E; Rizell M; Naredi P; Syk I
    BJS Open; 2021 Jul; 5(4):. PubMed ID: 34308474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients.
    Rosander E; Holm T; Sjövall A; Hjern F; Weibull CE; Nordenvall C
    Eur J Surg Oncol; 2021 Sep; 47(9):2398-2404. PubMed ID: 34112562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta-Analysis.
    Peng D; Cheng YX; Cheng Y
    Biomed Res Int; 2021; 2021():5541613. PubMed ID: 33997003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.